SPON2 / MINDIN (aa55-104) IHC-plus Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-SPON2 / MINDIN (aa55-104) IHC-plus antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | SPON2 / MINDIN (aa55-104) IHC-plus |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | mouse, rat, human |
| Isotype | n/a |
| Format | immunoaffinity purified |
| Size | 0.05 mL |
| Concentration | 1 mg/ml |
| Applications | Immunohistochemistry (IHC) Paraffin, Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: SPON2 Antibodyantibody detects endogenous levels of SPON2. SPON2 Antibody, DIL-1 Antibody, DIL1 Antibody, M-SPONDIN Antibody, Spondin-2 Antibody, MINDIN Antibody Description: Cell adhesion protein that promotes adhesion and outgrowth of hippocampal embryonic neurons. Binds directly to bacteria and their components and functions as an opsonin for macrophage phagocytosis of bacteria. Essential in the initiation of the innate immune response and represents a unique pattern-recognition molecule in the ECM for microbial pathogens By similarity. Binds bacterial lipopolysaccharide (LPS). |
| Immunogen | Immunogen Description: Synthetic peptide from human SPON2 (aa55-104). |
| Other Names | [Rabbit (IgG) to Human SPON2 / MINDIN; Human SPON2 / MINDIN; DIL-1; DIL1; M-SPONDIN; Spondin-2], [SPON2; SPON2; DIL1; DIL-1; MINDIN; M-SPONDIN; DIL1; DIL-1] |
| Gene, Accession # | [SPON2 / MINDIN], Gene ID: 10417, NCBI: NP_036577.1, UniProt: Q9BUD6 |
| Catalog # | MBS249947 |
| Price | $530 |
| Order / More Info | SPON2 / MINDIN (aa55-104) IHC-plus Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies